← Leaderboards
Chi-Huey Wong
Scripps Research Institute
$11,823,568
Attributed
$11,823,568
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $889.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,823,568 · 9
By mechanism
R01$8,335,415 · 3
R37$3,311,675 · 1
P01$113,837 · 1
P41$62,641 · 4
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Robert A. Terkeltaub$12,033,542
- Gerald F Joyce$4,317,222
- Subhash C Sinha$3,568,854
- Carlos F Barbas$17,256,782
Others in their field
Top investigators on “Oligosaccharides”
- Dennis L. Kasper · Harvard Medical School$27,868,053
- Geert-Jan Boons · University Of Georgia (Uga)$16,473,058
- Jacques U Baenziger · Washington University$12,267,027
- Jian None Liu · University Of North Carolina Chapel Hill$11,679,776
- Ajit P Varki · University Of California San Diego$11,487,386
- Wayne Lencer · Children'S Hospital Boston$11,480,415
Research focus
OligosaccharidesReceptorCarbohydratesDrug ResistanceComplexNeuraminidaseDesignInfectionStructureHemagglutininBaseInhibitor/AntagonistStructure-Activity RelationshipLibrariesDrug Design /Synthesis /ProductionSpecificityGlycoproteinsAntiviral AgentsCellsGlycopeptidesVirusNeuraminidase InhibitorGlycosylationCell Surface
Grant awards (35)
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy$446,200
R01 · FY2025 · AI · contact PI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy$452,500
R01 · FY2024 · AI · contact PI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy$483,750
R01 · FY2022 · AI · contact PI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy$483,750
R01 · FY2021 · AI · contact PI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy$483,750
R01 · FY2020 · AI · contact PI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy$483,750
R01 · FY2019 · AI · contact PI
Carbohydrate-based Antiinfective Agents$473,750
R01 · FY2014 · AI · contact PI
Carbohydrate-based Antiinfective Agents$445,325
R01 · FY2013 · AI · contact PI
Carbohydrate-based Antiinfective Agents$473,750
R01 · FY2012 · AI · contact PI
Carbohydrate-based Antiinfective Agents$473,750
R01 · FY2011 · AI · contact PI
Carbohydrate-based Antiinfective Agents$460,102
R01 · FY2010 · AI · contact PI
Carbohydrate-based Antiinfective Agents$464,749
R01 · FY2009 · AI · contact PI
PEPTIDE SURROGATES IN RAPID SYNTHESIS OF HIV PROTEASE INHIBITORS$38,851
P41 · FY2009 · RR · contact PI
Carbohydrate-based Antiinfective Agents$447,189
R01 · FY2008 · AI · contact PI
ENZYMES IN ORGANIC SYNTHESIS$438,548
R37 · FY2008 · GM · contact PI
PEPTIDE SURROGATES IN RAPID SYNTHESIS OF HIV PROTEASE INHIBITORS$3,368
P41 · FY2008 · RR · contact PI
Carbohydrate-based Antiinfective Agents$431,440
R01 · FY2007 · AI · contact PI
ENZYMES IN ORGANIC SYNTHESIS$430,396
R37 · FY2007 · GM · contact PI
PEPTIDE SURROGATES IN RAPID SYNTHESIS OF HIV PROTEASE INHIBITORS$7,639
P41 · FY2007 · RR · contact PI
ENZYMES IN ORGANIC SYNTHESIS$420,167
R37 · FY2006 · GM · contact PI
RNA as a Target for Intervention$344,583
R01 · FY2006 · GM · contact PI
PEPTIDE SURROGATES IN RAPID SYNTHESIS OF HIV PROTEASE INHIBITORS$12,783
P41 · FY2006 · RR · contact PI
ENZYMES IN ORGANIC SYNTHESIS$416,700
R37 · FY2005 · GM
RNA as a Target for Intervention$352,876
R01 · FY2005 · GM
ENZYMES IN ORGANIC SYNTHESIS$416,700
R37 · FY2004 · GM
RNA as a Target for Intervention$352,876
R01 · FY2004 · GM
ENZYMES IN ORGANIC SYNTHESIS$416,700
R37 · FY2003 · GM
ENZYMES IN ORGANIC SYNTHESIS$416,700
R37 · FY2002 · GM
DESIGNED AMINOGLYCOSIDES MIMETICS TARGETING RNA$274,492
R01 · FY2002 · GM
Design &Synthesis of retroviral protease inhibitors and associated RNA targets$0
P01 · FY2002 · GM
ENZYMES IN ORGANIC SYNTHESIS$355,764
R37 · FY2001 · GM
DESIGNED AMINOGLYCOSIDES MIMETICS TARGETING RNA$256,150
R01 · FY2001 · GM
DESIGN AND ORGANIC SYNTHESIS OF INHIBITORS OF FIV PROTEASE$0
P01 · FY2001 · GM
DESIGNED AMINOGLYCOSIDES MIMETICS TARGETING RNA$250,683
R01 · FY2000 · GM
DESIGN AND ORGANIC SYNTHESIS OF INHIBITORS OF FIV PROTEASE$113,837
P01 · FY2000 · GM